Background: Genitourinary syndrome of menopause (GSM) is common among breast cancer survivors, particularly during endocrine therapy, and vaginal laser therapy has been proposed as a nonhormonal option; CO2 and Er:YAG devices differ technically and their effects should not be assumed equivalent. Objective: To assess th...
A. Yordanov, E. Tsoneva, V. Dimitrova et al.· Journal of Clinical Medicine· 0 citations
Computed tomography (CT) plays an important role in oncologic surveillance after treatment of gynecological malignancies, including patients treated with vaginal electronic brachytherapy (eBT). This phantom study evaluated CT acquisition strategies for oncologic surveillance, focusing on radiation dose reduction and ob...
D. Kostova-Lefterova, F. Simeonov, D. Hitova-Topkarova et al.· Biomedical engineering and p...· 0 citations
Background: Polycystic ovary syndrome (PCOS) is the most prevalent endocrine condition among women of reproductive age. It is marked by metabolic and reproductive irregularities and is often linked to insulin resistance, dyslipidemia, and obesity. Diverse methods of treatment are employed to enhance metabolic and hormo...
V. Yanachkova, A. Yordanov, Antonia Yaneva et al.· Journal of Clinical Medicine· 0 citations
Objective: This study aims to evaluate the potential role of metformin as an adjunct to fertility-sparing treatment strategies for women with atypical endometrial hyperplasia/endometrial intraepithelial neoplasia (AEH/EIN) and early-stage endometrioid endometrial cancer (EEC), with particular emphasis on oncologic and...
A. Yordanov, E. Tsoneva, Stoyan Kostov et al.· Cancers· 0 citations
It is demonstrated that oncogenesis in LFS can be driven by partial impairment of functional p53, rather than dominant-negative or gain-of-function mutations alone.
Francesca M. Wright, Mariela Vasileva-Slaveva, A. Yordanov et al.· BMC Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
